CDEK
← All organizations

Deproco

For profitContributed to NME

Also known as: DEPROCO

Phase 1Phase 2Phase 3Phase 4

First marketed drug

Oct 10, 1984

First NDA

Apr 3, 2000

Last known activity

Mar 19, 2026

Defunct as of Jun 1, 2000

Timeline

1980s

  1. Jan 1, 1984

    Deproco— Founded

  2. Jan 22, 1985

    lidocaine— Marketing Organization

2000s

  1. Jan 1, 2000

    Septodont— Acquired

  2. Apr 3, 2000

    articaine— NDA Organization

  3. Jun 1, 2000

    Deproco— Defunct

  4. May 9, 2008

    phentolamine mesylate— NDA Secondary Org

Drugs by trial phase (1 distinct, 5 trials)

Phase 4 (0 own, 1 via acquisition)

Marketed drugs (9)

Subsidiaries (1 direct, 2 total across the full acquisition tree)

Details

Founded
Lancaster, PA, US Jan 1, 1984
First NDA
Apr 3, 2000
Last known activity
Mar 19, 2026

Notes

No evidence of research after 2000